To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12070 | Letermovir | 4 | Not Yet Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12070 | Letermovir | 4 | Not Yet Recruiting | 1 |